Exenatide
Effect on Weight Loss of Exenatide Versus Placebo
AstraZeneca · Phase 3 · Completed · Enrollment 196
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Group A | n/r | n/r | n/r | n/r |
| Group B | n/r | n/r | n/r | n/r |
Not shown
- Group A: endpoint not reported
- Group B: endpoint not reported